The Challenges of Analytical Method Validation of Designer Drugs in Non-Biological Samples by GC/MS
Hosted by Agilent Technologies, Tuesday May 15, 2012; Presented by Fran Diamond, NMS Labs Chemistry Technical Leader.
The new wave of designer stimulants that have become available has created new challenges for the analytical laboratories involved in drug identification work. The proliferation of analogous and isomeric forms of these substances has generated the need for new instrument technology, software solutions and scientific vigilance. Discussion includes the multitude of drugs that are available, the approach to analysis by GC/MS, and NMS Labs commitment to finding solutions to this ever changing environment.
(view as pdf)
« Return to Webinars & Presentations